Ptpn6 inhibits caspase-8- and Ripk3/Mlkl-dependent inflammation

Ptpn6 is a cytoplasmic phosphatase that functions to prevent autoimmune and interleukin-1 (IL-1) receptor-dependent, caspase-1-independent inflammatory disease. Conditional deletion of Ptpn6 in neutrophils ( Ptpn6 ∆PMN ) is sufficient to initiate IL-1 receptor-dependent cutaneous inflammatory diseas...

Full description

Saved in:
Bibliographic Details
Published in:Nature immunology Vol. 21; no. 1; pp. 54 - 64
Main Authors: Speir, Mary, Nowell, Cameron J., Chen, Alyce A., O’Donnell, Joanne A., Shamie, Isaac S., Lakin, Paul R., D’Cruz, Akshay A., Braun, Roman O., Babon, Jeff J., Lewis, Rowena S., Bliss-Moreau, Meghan, Shlomovitz, Inbar, Wang, Shu, Cengia, Louise H., Stoica, Anca I., Hakem, Razq, Kelliher, Michelle A., O’Reilly, Lorraine A., Patsiouras, Heather, Lawlor, Kate E., Weller, Edie, Lewis, Nathan E., Roberts, Andrew W., Gerlic, Motti, Croker, Ben A.
Format: Journal Article
Language:English
Published: New York Nature Publishing Group US 01-01-2020
Nature Publishing Group
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Ptpn6 is a cytoplasmic phosphatase that functions to prevent autoimmune and interleukin-1 (IL-1) receptor-dependent, caspase-1-independent inflammatory disease. Conditional deletion of Ptpn6 in neutrophils ( Ptpn6 ∆PMN ) is sufficient to initiate IL-1 receptor-dependent cutaneous inflammatory disease, but the source of IL-1 and the mechanisms behind IL-1 release remain unclear. Here, we investigate the mechanisms controlling IL-1α/β release from neutrophils by inhibiting caspase-8-dependent apoptosis and Ripk1–Ripk3–Mlkl-regulated necroptosis. Loss of Ripk1 accelerated disease onset, whereas combined deletion of caspase-8 and either Ripk3 or Mlkl strongly protected Ptpn6 ∆PMN mice. Ptpn6 ∆PMN neutrophils displayed increased p38 mitogen-activated protein kinase-dependent Ripk1-independent IL-1 and tumor necrosis factor production, and were prone to cell death. Together, these data emphasize dual functions for Ptpn6 in the negative regulation of p38 mitogen-activated protein kinase activation to control tumor necrosis factor and IL-1α/β expression, and in maintaining Ripk1 function to prevent caspase-8- and Ripk3–Mlkl-dependent cell death and concomitant IL-1α/β release. Croker and colleagues show that the phosphatase Ptpn6 functions to suppress neutrophil cell death pathways and IL-1 release, thereby limiting autoinflammatory responses.
Bibliography:Experiments: MS, AAC, JAO, AAD, ROB, JJB, RSL, MBM, IS, SW, LHC, AIS, HP, LAO, KEL, MG, BAC
Funding: AWR, EW, NEL, KEL, RH, MAK, JJB, CJN, BAC
Supervision: MS, AAC, JJB, EW, NEL, KEL, AWR, MG, BAC
Project design: MS, AAC, JAO, AAD, JJB, RSL, MBM, IS, KEL, AIS, AWR, MG, BAC
Software development: CJN
Analysis: MS, CJN, AAC, JAO, ISS, PRL, AAD, ROB, JJB, RSL, MBM, IS, SW, LHC, AIS, HP, KEL, EW, NEL, AWR, MG, BAC
Author Contributions
Writing: MS, JAO, KEL, NEL, IS, MG, BAC
ISSN:1529-2908
1529-2916
DOI:10.1038/s41590-019-0550-7